Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Biden again tests positive for COVID-19, says he feels fine

Published 30/07/2022, 20:04
Updated 31/07/2022, 05:45
© Reuters. FILE PHOTO - U.S. President Joe Biden listens as he receives an update on economic conditions from his advisors in the Eisenhower Executive Office Building's South Court Auditorium at the White House in Washington, U.S., July 28, 2022. REUTERS/Elizabeth F

By Jarrett Renshaw and Pete Schroeder

WASHINGTON (Reuters) -U.S. President Joe Biden tested positive for COVID-19 again on Saturday in what the White House doctor described as a "rebound" case seen in a small percentage of patients who take the antiviral drug Paxlovid.

Biden, 79, who emerged from COVID isolation on Wednesday after testing positive on July 21, said he was feeling fine.

He will now return to strict isolation and will cancel planned trips to his home in Wilmington and work trip in Michigan, the White House said. Biden held public events on Wednesday and Thursday, but none on Friday.

The forced isolation comes as the White House was hoping to celebrate some recent legislative victories to help boost Biden's slumping poll ratings.

Biden had planned the Michigan trip to tout Thursday's passage of legislation to boost the U.S. semiconductor chips industry.

Biden's positive test is believed to be a "rebound" experienced by some COVID patients who take the anti-viral drug Paxlovid, according to White House physician Dr. Kevin O'Connor. Paxlovid is an antiviral medication from Pfizer Inc (NYSE:PFE) that is used to treat high-risk patients, such as older patients.

A small but significant percentage of people who take Paxlovid will suffer a relapse or a rebound that occurs days after the five-day treatment course has ended, studies have shown.

White House officials had previously suggested a rebound case of COVID was unlikely, based on reports of cases around the country. However, Biden continued to be tested and monitored.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Biden tweeted about his positive case, saying it can happen to a "small minority of folks." He later posted a video on Twitter (NYSE:TWTR) where he said he was "feeling fine" and "everything's good."

A White House official said contact tracing efforts were underway Saturday after Biden's positive COVID-19 test.

National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci also experienced rebound COVID-19. His symptoms got worse when they returned after treatment, and his doctors prescribed another course of Paxlovid.

O'Connor said Biden tested negative for the last four days, and there is no plan to reinitiate treatment given his lack of symptoms.

Biden previously described his experience with COVID as mild, saying he was able to continue working while in isolation and attributed his relative ease with the disease to vaccines and other treatments.

O'Connor had previously said Biden would be tested regularly to watch for a potential "rebound" COVID-19 case, which can be experienced by some patients who have been treated with Paxlovid, the drug the president received.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.